Healthcare Press

Repurposing anti-retroviral medications for brain tumor treatment: The RETREAT trial

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 30 sec. here
  • 21 min. at publisher
  • 📊 Quality Score:
  • News: 81%
  • Publisher: 71%

AIDS News

Brain,Drugs,HIV

Drugs developed to combat HIV and AIDS are being trialed for the first time in patients with multiple brain tumors.

University of PlymouthJun 21 2024

The RETREAT clinical trial, led by Professor Oliver Hanemann, will expand on research by Dr Sylwia Ammoun and Professor Hanemann which showed the repurposed drugs reduced tumor growth and survival in the tumors. Dr Karen Noble, Director of Research, Policy and Innovation at Brain tumor Research, said: "Brain tumor Research is committed to funding research that will provide better outcomes for patients, so we are delighted that research undertaken at our Centre of Excellence has progressed into a clinical trial, bringing hope to patients with NF2 and NF2-related tumors.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

I'm not exaggerating when I say a wellness retreat changed my lifeI visited Santorini with Travelgems for a life-changing wellness retreat – here's what happened
Source: hellomag - 🏆 24. / 68 Read more »

Saltmoore: Luxury £10m wellness retreat in Sandsend to open in SeptemberA luxury new £10m ‘wellness retreat’ development is to open in North Yorkshire in September, developers have announced.
Source: The Yorkshire Post - 🏆 39. / 66 Read more »